President Trump's coronavirus task force urged to tap into the potential of community pharmacies in combatting the coronavirus pandemic.
Health Law & Policy
President Donald Trump has signed a bill that will provide more than $8.3 billion to fight the coronavirus disease outbreak.
In new comments to the US government, several pharmacy groups say that mergers of major companies have had significant anticompetitive effects without improving the cost and quality of health care.
Several pharmacy groups said they will file a brief in the Supreme Court case, Rutledge v. the Pharmaceutical Care Management Association.
NACDS praised the new Kaiser Permanente model, which utilizes pharmacists and pharmacy technicians to save significant health care costs.
Two new reports quantify the problem that community pharmacists have experienced firsthand.
CMS proposed taking action to increase transparency in Medicare Part D plan sponsors’ pharmacy performance measures.
A New Jersey law passed in mid-January requires pharmacies to provide drug disposal options and to educate their customers on how to safely dispose of unused, unwanted, or expired medications.
A pharmacy group is taking a wait-and-see approach after California Governor Gavin Newsom (D) announced several drug reforms–including a state generic prescription drug label.
The NACDS and NCPA praised the United States Supreme Court's decision to hear a case involving states’ regulation of pharmacy benefit managers.